Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Arenzana-Seisdedos

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Expert Review of Clinical Pharmacology|August 25, 2017
To which extent can we decrease antibiotic duration in critically ill patients?José Garnacho-Montero, Angel Arenzana-Seisdedos, Jan De Waele, et al.
Journal of Critical Care|September 15, 2018
Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unitJosé Garnacho-Montero, Cristina León-Moya, Antonio Gutiérrez-Pizarraya, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Expert Review of Clinical Pharmacology|August 25, 2017
To which extent can we decrease antibiotic duration in critically ill patients?José Garnacho-Montero, Angel Arenzana-Seisdedos, Jan De Waele, et al.
Journal of Critical Care|September 15, 2018
Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unitJosé Garnacho-Montero, Cristina León-Moya, Antonio Gutiérrez-Pizarraya, et al.
Pageof 1